AMY DOODY: Open Payments
NPI 1063426773 · CROMWELL, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,473 in 258 payments from 18 companies in 2025. Trend: 2023 $1,584 · 2024 $4,000 · 2025 $5,473
Food & beverage: $5,463Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $1,018 |
| UCB, Inc. | 23 | $839 |
| LEO Pharma Inc. | 25 | $532 |
| Janssen Biotech, Inc. | 16 | $393 |
| PFIZER INC. | 18 | $380 |
| Incyte Corporation | 25 | $340 |
| Amgen Inc. | 9 | $303 |
| Arcutis Biotherapeutics, Inc. | 14 | $255 |
| Regeneron Healthcare Solutions, Inc. | 9 | $243 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $236 |
Products named: Bimzelx, RINVOQ, ADBRY, TREMFYA, SKYRIZI, DUPIXENT, OPZELURA, CIBINQO.
Industry payments across CT — which companies pay providers there.
